Lupus myocarditis receiving the rituximab therapy: A monocentric retrospective study
Clinical Rheumatology Jan 13, 2018
Wang CR, et al. - This study sheds light on the value of rituximab (RTX) therapy in the treatment of refractory lupus myocarditis (LM). RTX therapy led to improved myocardial function in refractory LM patients.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
